Bio-Rad Laboratories Inc Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific | Outperform |
10
|
$597.15 | Buy/Sell | $591.94 | 3.83% | 1 | $227.94B |
| DHR | Danaher | Outperform |
10
|
$264.84 | Buy/Sell | $260.33 | 2.87% | 4 | $196.16B |
| A | Agilent Technologies | Outperform |
10
|
$154.31 | Buy/Sell | $138.82 | -2.15% | 10 | $45.22B |
| MTD | Mettler-Toledo International | Hold |
13
|
$1.53k | Buy/Sell | $1.12k | -13.10% | 0 | $32.69B |
| WAT | Waters | Hold |
15
|
$360.51 | Buy/Sell | $323.50 | -9.43% | 2 | $21.39B |
| ILMN | Illumina | Outperform |
16
|
$114.46 | Buy/Sell | $159.28 | 28.87% | 9 | $18.23B |
| AVTR | Avantor | Outperform |
16
|
$24.98 | Buy/Sell | $23.25 | 12.09% | 19 | $16.97B |
| PKI | PerkinElmer | Outperform |
16
|
$108.46 | Buy/Sell | $121.84 | 14.63% | 1 | $12.87B |
| BRKR | Bruker | Outperform |
16
|
$75.82 | Buy/Sell | $73.64 | 13.43% | 1 | $11.08B |
| COHR | Coherent | - |
12
|
$33.97 | Buy/Sell | $258.00 | -100.00% | 0 | $6.61B |
| LAB | Standard BioTools | Buy |
11
|
$2.50 | Buy/Sell | $4.00 | 40.00% | 1 | $856.71M |
| PACB | Pacific Biosciences of Califor... | Outperform |
9
|
$2.19 | Buy/Sell | $12.67 | 59.82% | 4 | $468.43M |
| HBIO | Harvard Bioscience | Buy |
14
|
$3.44 | Buy/Sell | $7.00 | 103.49% | 2 | $162.83M |
| EQTL | Equitech International | - |
0
|
$1.40 | Buy/Sell | $0.00 | -100.00% | 0 | $2.56M |
| ASPT | Haber | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% | 0 | $0.02M |
| MDIT | Medite Cancer Diagnostics | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% | 0 | $0.01M |
| OMRX | Orthometrix | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% | 0 | $0.00M |
| LFPI | LifePoint | - |
0
|
$0.00 | Buy/Sell | $5.50 | 0.00% | 0 | $0.00M |